To combat COVID-19, Moderna launched a Phase 1 study consisting of 45 participants in an effort to create a vaccine on an expedited timeline. March 16th was the start of the Phase 1 testing. The initial group of 45 people were divided into groups of 15 individuals. Each grouping received 2 doses of treatment, but each group received a different dosage of the proposed vaccine (25, 100, or 250 microgram dosages). The subjects who received both doses, showed higher levels of virus-defeating antibodies when compared to individuals who had recovered from the coronavirus. The majority of participants who received both dosages did report adverse reactions, as to be expected during the trials.
Food producers have been overlooked during the COVID-19 pandemic, they have been working tirelessly to keep our grocery stores stocked. Sanderson Farms Inc. just reported the first positive case at a major U.S meat producer. Seven employees from the Sanderson Farms plant in Mississippi were sent home to quarantine, but the plant remains operating at full capacity. Food producers are often at high risk for this virus as employees often work in close proximity of one another picking fruits or cutting and packaging meats, it is likely that we continue to see more and more reported cases. It is also important to note that COVID-19 is not a food born virus.